Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

Ítems similars

• Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia
  per: Sohn, Hyun-Jung, et al.
  Publicat: (2017)
• Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy
  per: Shin, Chang-Ae, et al.
  Publicat: (2016)
• A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
  per: Cho, Hyun-Il, et al.
  Publicat: (2018)
• Measurement of CD8(+) and CD4(+) T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs
  per: Sohn, Dae-Hee, et al.
  Publicat: (2015)
• Selective Bowel Decontamination for the Prevention of Infection in Acute Myelogenous Leukemia: A Prospective Randomized Trial
  per: Lee, Dong Gun, et al.
  Publicat: (2002)